Morning news brief: USFDA advisors okay COVID vaccine, Johnson mulls no-deal Brexit, more
Morning news brief
A panel of outside advisors to the US Food and Drug Administration (FDA) has voted to endorse the emergency use of Pfizer Inc's coronavirus vaccine. This paves the way for USFDA to clear the vaccine for its use in the US. Brexit trade deal talks between Britain and European Union (EU) are still in uncertain stage. UK PM Boris Johnson has said that there was 'strong possibility' of a no-deal Brexit. Read this and more in our morning new brief.
BioNTech last month said a two-dose regimen of the vaccine was 95% effective in preventing illness from COVID-19.
The trade deal talks between EU and Britain are stuck on issues such as competition rules, fishing rights and economic fair play
His comments came just a day after Canada's health regulators granted emergency approval Pfizer/BioNTech vaccine. 30,000 doses will arrive in Canada in the beginning
A spokesperson for the US State Department further called on any Eritrean soldiers there to pull out.
On information, the bomb disposal unit of the Air Force's Bangabandhu Base rushed to the spot and defused the 250-kg bomb, the Defence Ministry said in a statement.